With the reimbursement uncertainty behind them, they can now concentrate on trying to push their recurring revenue model forward. The CEO has a lot of work ahead of him, in order to win back reputation. I’ve always been perplexed at why the business doesn’t grow faster, given the alleged benefits of their technology versus comps.. the benefit with recovery and cosmetic appearance after the procedure should speak for itself?
With the reimbursement uncertainty behind them, they can now concentrate on trying to push their recurring revenue model forward. The CEO has a lot of work ahead of him, in order to win back reputation. I’ve always been perplexed at why the business doesn’t grow faster, given the alleged benefits of their technology versus comps.. the benefit with recovery and cosmetic appearance after the procedure should speak for itself?